Naseem Amin

Director, Bellerophon Therapeutics (United States).

Companies

Avadel PharmaceuticalsBoard member May 21, 2024 to now¹
Bellerophon Therapeutics (United States)Board member Jul 1, 2015 to Jun 9, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Avadel Pharmaceuticals AVDL0 shares³Feb 12, 2026
Bellerophon Therapeutics (United States)291,865 shares⁴Jun 7, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 12, 2026Returned to company 22,000 shares at $21.00 of Avadel Pharmaceuticals³
Jul 29, 2025Granted 11,000 shares of Avadel Pharmaceuticals⁵
Jul 30, 2024Granted 11,000 shares of Avadel Pharmaceuticals⁶
Jun 7, 2023Granted 47,578 shares of Bellerophon Therapeutics (United States)⁴
Feb 10, 2023Granted 84,000 shares of Bellerophon Therapeutics (United States)⁷
Dec 31, 2021Granted 39,032 shares of Bellerophon Therapeutics (United States)⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAvadel Pharmaceuticals, Board member
2
SEC EDGARBellerophon Therapeutics (United States), Board member
3
SEC EDGARAvadel Pharmaceuticals shares after the filing of Feb 12, 2026
4
SEC EDGARBellerophon Therapeutics (United States) shares after the filing of Jun 7, 2023
5
SEC EDGARForm 4 filed Jul 31, 2025
6
SEC EDGARForm 4 filed Aug 1, 2024
7
SEC EDGARForm 4 filed Feb 14, 2023
8
SEC EDGARForm 4 filed Jan 4, 2022